OmniAb Quarterly Cash Flow Statement
NASDAQ: OABIHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
4.79+0.13 (+2.79%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OmniAb free cash flow
In the quarter ended Jun 30, 2026, OmniAb generated $2.7 million of operating cash flow and spent $110,000 on capital expenditures. That left free cash flow of $2.6 million, a free-cash-flow margin of 19.2% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
OmniAb cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -5.86M | -7.71M | -14.18M | -16.52M | -15.88M | -18.20M | -13.07M | -16.37M | -13.63M | -18.96M | -14.05M | -15.74M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | -306.06% | -738.09% |
| Depreciation & Amortization | 600.00K | 606.00K | 7.71M | 4.66M | 4.65M | 4.74M | 7.61M | 4.93M | 6.10M | 4.95M | 4.93M | 4.84M |
| Stock-Based Compensation | 3.16M | 3.34M | 3.61M | 3.96M | 4.11M | 4.14M | 5.12M | 5.30M | 5.38M | 5.70M | 5.93M | 6.31M |
| Change in Working Capital | 2.27M | -7.11M | -2.30M | 44.00K | 4.48M | -4.97M | -746.00K | 2.87M | -5.37M | -5.13M | 158.00K | 3.19M |
| Operating Cash Flow | 2.68M | -4.91M | -5.67M | -9.76M | -5.15M | -15.87M | -3.87M | -6.58M | -12.18M | -17.03M | -9.12M | -6.20M |
| Capital Expenditures | -110.00K | -167.00K | -9.00K | -182.00K | -165.00K | -209.00K | -46.00K | -152.00K | -751.00K | -926.00K | -107.00K | -490.00K |
| Investing Cash Flow | -7.62M | 8.44M | 2.71M | -7.67M | 12.30M | -878.00K | 385.00K | 4.45M | 13.11M | 19.94M | 4.73M | 6.29M |
| Financing Cash Flow | 233.00K | 0 | -50.00K | 27.68M | 236.00K | 44.00K | 3.85M | 8.57M | 803.00K | -203.00K | -496.00K | 171.00K |
| Net Change in Cash | -4.71M | 3.52M | -3.01M | 10.26M | 7.39M | -16.71M | 362.00K | 6.44M | 1.73M | 2.70M | -4.89M | 259.00K |
| Free Cash Flow | 2.57M | -5.08M | -5.68M | -9.95M | -5.31M | -16.08M | -3.92M | -6.73M | -12.93M | -17.96M | -9.23M | -6.69M |
This table shows 12 quarterly periods of OmniAb's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OABI's reporting calendar. What is a cash flow statement?